Diagnostic companies rely heavily on the ability to process data efficiently and at scale in order to achieve both commercial growth and technological advancement. However, many of these companies face significant challenges in building and maintaining the infrastructure necessary to process data effectively.

Poised to transform and revolutionize our understanding of biology and disease, spatial transcriptomic data (ST) provides valuable insights into the spatial organization of gene expression at the tissue level, cellular-level and subcellular level.